O
6.62
0.03 (0.38%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Ocular Therapeutix, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 价值 35% | -0.1 |
| AI Insight 参考 | NA |
| 相对估值 参考 | NA |
| 财务健康 参考 | -0.1 |
| 时机 35% | -0.4 |
| AI Technical 参考 | NA |
| 技术振荡指标 参考 | -4.0 |
| 技术平均移动指标 参考 | 5.0 |
| 聪明钱 30% | 0.0 |
| 分析师共识 参考 | 0.0 |
| 内部交易活动 参考 | NA |
| 市场环境 | ×1.21 |
| 宏观环境 参考 | -3.3 |
| 行业对比大市 (6个月) | -21.3% |
| 支柱一致性 | ×1.25 |
| 不计入评分 | |
| 价格波动 参考 | 3.1 |
| 最终评分 | -0.27 |
|
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 3.82% |
| 机构持股比例 | 87.01% |
该时间范围内无数据。
该时间范围内无数据。
投资组合